Enrolled cats were 6-21years of age , with owner-observed mobility impairment , evidence of pain in at least 2 joints during orthopedic examination , and overlapping radiographic evidence of DJD , and underwent a 2-week baseline period , 3-week treatment period with placebo or meloxicam , and 3-week masked washout period .